InvestorsHub Logo
Followers 0
Posts 16
Boards Moderated 0
Alias Born 06/13/2010

Re: DonShimoda post# 326

Sunday, 06/13/2010 7:59:00 PM

Sunday, June 13, 2010 7:59:00 PM

Post# of 80490
Obviously you dont how much it costs for ongoing trials just as much as I dont. But answer this question ?

How much money do you think it takes to develop a drug and to fund all clinical trials until the drug reaches approval ?

Can you answer that question ?

I can't but I can use my Las Vegas gambling instinct to suggest that it will be well over $100 million.

Now I am not implying that ARIA cannot do it as you seem to think that I do, but I do know the hazards of biotech investing and advancing drugs thru trials is a money pit. It is the biggest drain on a balance sheet plain and simple. If you dont have the cash then trial will not be large enough or will not be as specific as you would like.

A quote from a prees release regarding RIDA:

"Merck has spent more than $200 million on the partnership so far, including about $128.5 million in milestone payments. Last year, the companies canceled one late-stage trial and delayed another. That cost Ariad millions in milestone payments."

Now let me ask the question again

How much money do you think it takes to develop a drug and to fund all clinical trials until the drug reaches approval ?

As matter of disclosure I own ARIA options and I would recommend buying at these levels.

Remember that when you and Surf start picking at my posts

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.